Physicians
Physician for Urolift

Welcome

Welcome to the medical professionals’ information center. NeoTract, Inc. is committed to helping medical professionals provide the best care for their patients by developing innovative devices that address unmet clinical needs in urology.

 

The UroLift® System

LUTS due to benign prostatic hyperplasia affects millions of men every year. While these men can select from a variety of treatment options, from medication to major surgery, there has been a gap in the treatment continuum for a less invasive option.

The UroLift® System was designed to meet this need. With its unique design and mechanism of action, the UroLift System is a simple procedure that provides immediate, visible results. The procedure can be done in an outpatient or inpatient setting and under general or local anesthesia. Patients typically can return home the same day without a catheter. With significant symptom relief outcomes and a fewer side effects, the UroLift System can be a first line treatment for patients who prefer an alternative to medication or major surgery.

 

The UroLift System Procedure

The UroLift System works by lifting and holding the enlarged prostate tissue out of the way, like opening curtains on a window, to relieve the compression on the urethra. The UroLift Delivery Device is used to deliver the implants to the prostate lobes without any cutting, heating or removing of prostate tissue. Typically, 4-6 implants are placed.

UroLift Animation Video

UroLift Case Video

 

The UroLift Delivery Device

The UroLift System is comprised of two main components:The UroLift Delivery Device

  • UroLift Delivery Device, which is used to deliver the implants
  • UroLift Implant, a trans-prostatically tailored permanent implant made with common implantable materials: nitinol, stainless steel, PET suture

Non-clinical testing has demonstrated that the UroLift Implant is MR Conditional. A patient with this device can be safely scanned in an MR system immediately after placement meeting the following conditions:

  • Static magnetic field of 1.5 Tesla or 3.0 Tesla or less, only
  • Maximum spatial field gradient of 1,500 Gauss/cm (15 T/m) (extrapolated) or less
  • Maximum MR system reported, whole body averaged specific absorption rate (SAR) of 4 W/kg for 15 minutes of scanning (i.e. per pulse sequence) (First Level Controlled Operating Mode)

Under the scan conditions defined above, the UroLift Implant is expected to produce a maximum temperature rise of 2.2°C after 15 minutes of continuous scanning (i.e., per pulse sequence).

In non-clinical testing, the image artifact caused by the device extends approximately 15 mm from the UroLift Implant when imaged with a gradient echo pulse sequence and a 3.0 Tesla MRI system.

The safety of the delivery system has not been evaluated in the MR environment, and therefore, the delivery system should not be used within the MR environment.